Hydronephrosis Complicating Endometriosis in a Case of Infiltrating Lobular Carcinoma of the Breast Treated with Tamoxifen
Case report
OA: closed
CC0
AI-generated summary
This case report describes a patient with breast cancer treated with tamoxifen who developed hydronephrosis secondary to extra-uterine endometriosis, highlighting this rare complication of the therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Uterine endometrialpolyp, hyperplasia and malignant transformation are well known side effects of Tamoxifen use in breast cancer patients. We present a case of hydronephrosis secondary to extra-uterine endometriosis in a female with mixed Invasive Ductal Carcinoma (IDC) and Invasive Lobular Carcinoma (ILC) of the breast on adjuvant tamoxifen.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-10-09T06:36:44.367587+00:00
License: CC0
· commercial use OK